Contribution of inflammation to heart failure development in human immunodeficiency virus-infected patients
Aim. To determine the peculiarities of heart failure (HF) development in human immunodeficiency virus (HIV)-infected patients, depending on the blood concentration of C-reactive protein (CRP).Material and methods. This cross-sectional screening clinical trial included 100 patients hospitalized with...
Main Authors: | N. A. Koziolova, O. G. Goryacheva, I. F. Litsinger |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2022-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4862 |
Similar Items
-
Heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2020-02-01) -
Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2022-03-01) -
Human Immunodeficiency Virus Infection-Associated Cardiomyopathy and Heart Failure
by: Aikaterini Papamanoli, et al.
Published: (2022-10-01) -
Risk factors of severe heart failure in HIV-positive patients
by: O. G. Goryacheva, et al.
Published: (2021-02-01) -
Heart failure with reduced ejection fraction in people living with human immunodeficiency virus/acquired immunodeficiency syndrome
by: Shailesh Singh, et al.
Published: (2020-01-01)